H Vernon Anderson1, Robin Jacob2. 1. Cardiology Division, University of Texas Health Science Center, McGovern Medical School, Memorial Hermann Heart & Vascular Institute, 6431 Fannin, MSB-1.246, Houston, TX, 77030, USA. h.v.anderson@uth.tmc.edu. 2. Cardiology Division, University of Texas Health Science Center, McGovern Medical School, Memorial Hermann Heart & Vascular Institute, 6431 Fannin, MSB-1.246, Houston, TX, 77030, USA.
Abstract
PURPOSE OF REVIEW: This review summarizes and discusses the evidence base supporting current performance and quality measures used in assessing institutions in their care of patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS). RECENT FINDINGS: Professional societies in the USA and Europe have developed performance and quality measures for NSTE-ACS. These measures are reviewed and updated periodically to reflect the most important evidence from the literature. In the USA, the ACC/AHA Task Force on Performance Measures published the updated 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction. In Europe, the ESC Acute Cardiac Care Association published the 2017 Quality Indicators for acute myocardial infarction. These documents build on guidelines previously developed and published by the two organizations. They include detailed reviews of current and past studies establishing that adherence with guidelines improves clinical outcomes. Both measure sets provide quantitative methodologies to assess program performance. Institutional programs that focus on these validated measures can increase guideline adherence, streamline and standardize care processes, and reduce morbidity and mortality. Performance and quality measures have become a critical part of healthcare today, allowing patients, providers, administrators, and payors to assess patient care objectively. They are also becoming an important component of value-based payment programs. To be fair, and useful, for internal institutional assessment, in comparing different institutions, and for value-based payments, only validated performance measures such as these should be employed.
PURPOSE OF REVIEW: This review summarizes and discusses the evidence base supporting current performance and quality measures used in assessing institutions in their care of patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS). RECENT FINDINGS: Professional societies in the USA and Europe have developed performance and quality measures for NSTE-ACS. These measures are reviewed and updated periodically to reflect the most important evidence from the literature. In the USA, the ACC/AHA Task Force on Performance Measures published the updated 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction. In Europe, the ESC Acute Cardiac Care Association published the 2017 Quality Indicators for acute myocardial infarction. These documents build on guidelines previously developed and published by the two organizations. They include detailed reviews of current and past studies establishing that adherence with guidelines improves clinical outcomes. Both measure sets provide quantitative methodologies to assess program performance. Institutional programs that focus on these validated measures can increase guideline adherence, streamline and standardize care processes, and reduce morbidity and mortality. Performance and quality measures have become a critical part of healthcare today, allowing patients, providers, administrators, and payors to assess patient care objectively. They are also becoming an important component of value-based payment programs. To be fair, and useful, for internal institutional assessment, in comparing different institutions, and for value-based payments, only validated performance measures such as these should be employed.
Authors: C P Cannon; A Battler; R G Brindis; J L Cox; S G Ellis; N R Every; J T Flaherty; R A Harrington; H M Krumholz; M L Simoons; F J Van De Werf; W S Weintraub; K R Mitchell; S L Morrisson; R G Brindis; H V Anderson; D S Cannom; W R Chitwood; J E Cigarroa; R L Collins-Nakai; S G Ellis; R J Gibbons; F L Grover; P A Heidenreich; B K Khandheria; S B Knoebel; H L Krumholz; D J Malenka; D B Mark; C R Mckay; E R Passamani; M J Radford; R N Riner; J B Schwartz; R E Shaw; R J Shemin; D B Van Fossen; E D Verrier; M W Watkins; D R Phoubandith; T Furnelli Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: John A Spertus; Kim A Eagle; Harlan M Krumholz; Kristi R Mitchell; Sharon-Lise T Normand Journal: J Am Coll Cardiol Date: 2005-04-05 Impact factor: 24.094
Authors: Alexander Kulik; Marc Ruel; Hani Jneid; T Bruce Ferguson; Loren F Hiratzka; John S Ikonomidis; Francisco Lopez-Jimenez; Sheila M McNallan; Mahesh Patel; Véronique L Roger; Frank W Sellke; Domenic A Sica; Lani Zimmerman Journal: Circulation Date: 2015-02-09 Impact factor: 29.690
Authors: Ana-Catarina Pinho-Gomes; Luis Azevedo; Jung-Min Ahn; Seung-Jung Park; Taye H Hamza; Michael E Farkouh; Patrick W Serruys; Milan Milojevic; Arie Pieter Kappetein; Gregg W Stone; Andre Lamy; Valentin Fuster; David P Taggart Journal: J Am Coll Cardiol Date: 2018-02-13 Impact factor: 24.094
Authors: Harlan M Krumholz; Jeffrey L Anderson; Brian L Bachelder; Francis M Fesmire; Stephan D Fihn; JoAnne M Foody; P Michael Ho; Mikhail N Kosiborod; Frederick A Masoudi; Brahmajee K Nallamothu Journal: J Am Coll Cardiol Date: 2008-12-09 Impact factor: 24.094
Authors: Robin Mathews; William Wang; Lisa A Kaltenbach; Laine Thomas; Rashmee U Shah; Murtuza Ali; Eric D Peterson; Tracy Y Wang Journal: Circulation Date: 2018-01-31 Impact factor: 29.690